Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 80Sarcoma 61Gynecologic 20Thoracic 18Breast 18Gastrointestinal 16Other solid neoplasm 15Head & Neck 12CNS 10Endocrine 8Tumor-Agnostic 7Dermatologic 6Plasma cell 3NET 3Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 1Lymphoma 1

Interventions

Rituximab 1401Cyclophosphamide 1305Vincristine 668Doxorubicin 587Etoposide 527Prednisone 510Cytarabine 486fludarabine 469Methotrexate 445Dexamethasone 413fludarabine phosphate 400Lenalidomide 356Filgrastim 343Bendamustine Hydrochloride 282Radiotherapy 267venetoclax 260ibrutinib 258obinutuzumab 235Peripheral Blood Stem Cell Transplantation 234Melphalan 230Granulocyte Colony-Stimulating Factor 215Bortezomib 204Gemcitabine 202Busulfan 188Whole-Body Irradiation 187Mycophenolic Acid 175Tacrolimus 165Specimen Handling 162Magnetic Resonance Spectroscopy 155Calcium Dobesilate 150

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
pazopanib × Lymphoid × Clear all
NCT00674024 2019-11-20

Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
8 enrolled
Lymphoid

Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡